conbercept   Click here for help

GtoPdb Ligand ID: 14582

Synonyms: KH902 | KH903 | Lumitin® (China)
Approved drug
conbercept is an approved drug
Compound class: Peptide
Comment: Conbercept is a VEGF ligand trap. It comprises VEGF binding domains from VEGF receptors 1 and 2 including VEGFR-2 domain 4, fused to a human IgG Fc domain. Conbercept binds to and neutralizes all VEGF isoforms [4].
No information available.
Summary of Clinical Use Click here for help
Conbercept has been approved for clinical use in China since 2013 [1]. Intravitreally administered conbercept is used to treat neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT02194634 Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing) Phase 3 Interventional Chengdu Kanghong Biotech Co., Ltd. 2
NCT03108352 Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion Phase 3 Interventional Chengdu Kanghong Biotech Co., Ltd. 3